How have CRVO and NSPR total returns compared?

Over the past 10 years, CRVO delivered -53.96% and NSPR delivered -68.24% annualized total return. Past performance doesn't predict future results.

CervoMed Inc. (CRVO) vs InspireMD, Inc. (NSPR)

A side-by-side comparison of CervoMed Inc. and InspireMD, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CRVO

CervoMed Inc.

$31M

$3.34HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

NSPR

InspireMD, Inc.

$25M

$0.53HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CRVO vs NSPR

growth of $100 · dividends reinvested · last 10y

CRVO -100.0% (-54.0%/yr)NSPR -100.0% (-68.2%/yr)CRVO compounded faster over this window

Log scale — wide-divergence pair

CRVO NSPR

CRVO vs NSPR: by the numbers

•CRVO is the larger company ($31M vs $25M market cap).
•Both run net losses; NSPR's is the smaller (-355.17% vs -9408.76% net margin).

Metrics side by side

Valuation

Metric	CRVO	NSPR
P/S ratio	95.87	2.27
P/B ratio	1.35	0.78

Profitability

Metric	CRVO	NSPR
Gross margin	0.00%	29.50%
Operating margin	0.00%	-546.97%
Net margin	-9408.76%	-355.17%
ROE	-132.18%	-122.19%
ROIC	-135.73%	-153.04%

Growth (annualized)

Metric	CRVO	NSPR
Revenue CAGR (5Y)	N/A	27.79%
Total return CAGR (5Y)	-38.25%	-36.91%

Frequently asked

How have CRVO and NSPR total returns compared?: Over the past 10 years, CRVO delivered -53.96% and NSPR delivered -68.24% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CRVO analysis Full NSPR analysis Interactive comparison tool

Dig into the metrics

CervoMed ROE InspireMD ROE CervoMed operating margin InspireMD operating margin CervoMed revenue growth InspireMD revenue growth CervoMed free cash flow InspireMD free cash flow

CervoMed & InspireMD appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.